Peter Rudolph

Peter Rudolph is a seasoned professional in research and development program management, currently serving as Portfolio Lead Antibodies and Senior Director at BioNTech SE since January 2022. With extensive experience in overseeing and integrating multiple research projects and development programs, Peter plays a crucial role in shaping the Antibody Drug Portfolio's strategy and operational execution. Prior to BioNTech, Peter held various leadership positions at Sandoz from June 2006 to December 2021, including Sr. Global Program Team Director and Global Program Leader, where expertise in drug development and cross-functional team leadership was demonstrated. Peter also has foundational experience in pharmacy, having worked as a pharmacist at Ludwigs-Apotheke and healthcare training at Novartis, after earning a State examination in Pharmacy from the University of Regensburg.